Account Info
Log Out
English
Back
Download
Log in to access Online Inquiry
Quotes
Detailed Quotes
Company Overview
Company ProfileCompany Executives
Financial Analysis
Main CompositionKey IndicatorsFinancial Statement
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > FRTX Fresh Tracks Therapeutics > Key Indicators
FRTX Fresh Tracks Therapeutics
0.701
-0.029-3.97%
YOY
Do not show
Hide blank lines
(Q3)2022/09/30(Q2)2022/06/30(Q1)2022/03/31(FY)2021/12/31
Financial Ratios
Efficiency Ratios TTM
Receivable Turnover（T）
-- 13.4328 -- 12.9693 -- 5.2065 -- --
Fixed Assets Turnover（T）
1,441.08% 42.3475 1,567.49% 39.8541 -21.73% 5.6686 -72.01% 3.6561
Total Asset Rate（T）
1,901.06% 0.2587 1,536.06% 0.1952 -47.45% 0.0161 -81.88% 0.0128
ROIC
30.15% -144.780% -5.88% -156.876% -21.36% -175.476% -27.01% -150.183%
ROE
31.13% -145.183% -4.37% -157.289% -19.77% -176.487% -25.89% -151.700%
ROA
27.28% -117.210% -11.41% -125.586% -34.40% -133.732% -54.27% -124.620%
Efficiency Ratios
ROE 5 Year Average
-- -- -- -- -- -- -54.63% -74.655%
ROA 5 Year Average
-- -- -- -- -- -- -59.17% -57.598%
Average 5 Years ROIC
-- -- -- -- -- -- -56.31% -72.369%
Profitability Ratios TTM
Operating Margin
96.32% -465.199% 93.15% -657.527% -160.04% -8486.221% -765.26% -9961.386%
Net Margin
96.37% -453.112% 93.19% -643.485% -155.75% -8325.470% -751.26% -9770.792%
EBITDA Margin
96.36% -4.5235% 93.18% -6.4267% -155.73% -83.1148% -749.70% -97.4827%
R & D Expense Ratio
-96.79% 291.310% -92.57% 457.010% 219.59% 5885.590% 1,035.15% 6987.870%
Sales Expense Ratio
-- 0.000% -- 0.000% -- 0.000% -- 0.000%
Administration Expense Rate
-92.53% 273.880% -91.52% 300.520% 77.46% 2700.630% 383.50% 3073.510%
Financial Health Ratios
Total Assets to Common Equity
6.27% 128.727% -9.00% 118.354% -2.82% 129.543% -3.74% 119.312%
Debt to Asset Ratio
-56.13% 0.160% -40.16% 0.230% -80.31% 0.330% -85.29% 0.277%
Current Ratio
-22.66% 4.4265 47.00% 6.3592 5.59% 4.3647 16.60% 6.1538
Quick Ratio
-27.28% 3.7007 43.03% 5.223 -1.12% 3.6661 17.91% 5.5892
GrowthRatios
Growth Ratios
Revenue CAGR（3Y）
-- -- -- -- -- -- 24.48% -37.082%
Revenue CAGR（5Y）
-- -- -- -- -- -- -32.38% -51.155%
Currency Unit
USDUSDUSDUSD

FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC.

Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months.

The MOM data from the Quarterly report，MOM=(current period - last period)/last period *100%

Company Overview More
CEO： Mr. Andrew D. Sklawer
Market： NASDAQ
Listing Date： 03/09/1993
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist